Masimo Corporation (NASDAQ:MASI), a medical technology company valued at $9.36 billion, reported on Friday the resignation of board member Robert Chapek. The departure is set to take effect on the ...

The Financial Times reports today that an activist investor wants BD (NYSE:BDX) to sell off its Life Sciences business unit.

Learn more about whether ICU Medical, Inc. or Masimo Corporation is a better investment based on AAII's A+ Investor grades, ...

Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO. The Irvine-based medical device maker last week announced ...

Masimo appointed Katie Szyman as its next chief executive officer after a proxy fight forced out the company’s founder.

Learn more about whether Masimo Corporation or UFP Technologies, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Piper Sandler analyst Jason Bednar maintained a Buy rating on Masimo (MASI – Research Report) today and set a price target of $210.00. The ...

Szyman led Edwards Lifesciences’ critical care unit for more than a decade before BD acquired the group last year. Her ...

KBC Group NV grew its position in Masimo Co. (NASDAQ:MASI – Free Report) by 1,393.9% during the 4th quarter, Holdings Channel reports. The firm owned 19,122 shares of the medical equipment provider’s ...

Masimo (Nasdaq: MASI) + Masimo Corporation $172.4 1.44% Open 173.198 Day High 175.067 52 Week High 147.89 52 Week Low 75.22 announced today that it appointed Katie Szyman as its new CEO, effective Feb ...

Masimo Co. (NASDAQ:MASI – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seven brokerages ...

IRVINE, Calif.--(BUSINESS WIRE)--Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointed the next Chief ...